Daily vs Intermittent Iron Therapy in Pregnancy
common.study.values.description
“Daily vs Intermittent Iron Therapy in Pregnancy”
This is a randomized non inferiority trial to evaluate the response to iron therapy in the standard daily vs. intermittent (three-four times a week on nonconsecutive days) groups by using hematological markers (hemoglobin, hematocrit, transferrin, hepcidin, ferritin, human soluble transferrin receptor). The secondary outcome is to evaluate gastrointestinal discomfort and adherence to therapy between two treatment groups.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-no
Dietary Supplement - Ferrous Sulfate
Patients would be randomized to either taking ferrous sulfate daily or every other day (on non consecutive days).
participant.views.study.view.additional
participant.views.study.view.scientific-title
Daily vs. Intermittent Iron Therapy in Iron Deficient Pregnant Patients: A Randomized Noninferiority Trial
common.study.values.clinical-trial-id
NCT03706638
participant.views.study.view.id
bW6qJa
